© Copyright 2025 American Medical Association. All rights reserved.
Intracutaneous (intradermal) allergy tests, as described by CPT® Code 95015, are diagnostic procedures used to identify immediate type allergic reactions to various substances, including drugs, biologicals, or venoms. During this procedure, a physician administers small amounts of these test substances directly into the dermal layer of the skin. This method is particularly effective for assessing hypersensitivity reactions, as it allows for a more localized and controlled evaluation of the skin's response to potential allergens. The physician closely monitors the injection sites for signs of an allergic reaction, which may include swelling, redness, and itching. Following the administration of the tests, the physician interprets the results, documenting the findings in a written report. This report details the number of tests conducted, the specific allergenic extracts utilized, and the observed reactions, categorizing them as absent, present, or varying in degree. This comprehensive approach ensures that the results are clear and informative for further clinical decision-making.
© Copyright 2025 Coding Ahead. All rights reserved.
Intracutaneous (intradermal) allergy tests are indicated for the evaluation of immediate hypersensitivity reactions to specific allergens. These tests are commonly performed in patients who exhibit symptoms suggestive of allergic conditions, including but not limited to:
The procedure for conducting intracutaneous allergy tests involves several key steps, which are outlined as follows:
After the completion of the intracutaneous allergy tests, patients may experience mild reactions at the injection sites, such as localized redness or swelling, which typically resolve within a few hours. The physician may provide instructions for post-procedure care, including recommendations to avoid scratching the test sites and to monitor for any delayed reactions. Patients are advised to contact their healthcare provider if they experience significant discomfort or any unusual symptoms following the tests. The results of the tests will guide the physician in developing an appropriate management plan for the patient's allergies, which may include avoidance strategies or potential treatment options.
Short Descr | ID ALLERGY TITRATE-DRUG/BUG | Medium Descr | IQ TSTS SEQL&INCRL RX/BIOLOGIC/VNM IMMT RXN | Long Descr | Intracutaneous (intradermal) tests, sequential and incremental, with drugs, biologicals, or venoms, immediate type reaction, including test interpretation and report by a physician, specify number of tests | Status Code | Active Code | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 0 - No payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Discontinued Code | Type of Service (TOS) | 1 - Medical Care | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 173 - Other diagnostic procedures on skin and subcutaneous tissue |